A 49-year-old Caucasian man was admitted to the Emergency Department for shortness of breath and cough. Computed tomog raphy (CT) imaging showed bilateral mild COVID-19-related pneumonia. He was hospitalized in the low-intensity COVID-19 unit, where he received O2 therapy and oral corticosteroids. Three weeks after discharge, a high-resolution CT (HRCT) found a giant bulla in the inferior lobe. The bulla was resected by video-assisted thoracoscopic surgery, and the patient recovered completely. In our patient, it is reasonable to suspect that the development of the bulla is a result of SARS-CoV-2 infection since no bulla was observed in the first HRCT two months before. SARS-CoV-2related pneumonia may be responsible for lung remodeling due to diffuse alveolar damage and later interstitial myofibroblastic proliferation. Corticosteroids might have played a role in increasing SARS-CoV-2 dystrophic action. COVID-19 leads to pulmonary damages, which are still partially unknown and might result in the development of bullae. In fit patients, surgical treatment can be carried out safely.
Petroncini, M., Valentini, L., Solli, P., Bertoglio, P. (2023). Giant lung bulla as a late-onset complication of mild SARS-CoV-2 pneumonia. MONALDI ARCHIVES FOR CHEST DISEASE, 94(3), 1-3 [10.4081/monaldi.2023.2559].
Giant lung bulla as a late-onset complication of mild SARS-CoV-2 pneumonia
Petroncini M.;Valentini L.;Bertoglio P.
2023
Abstract
A 49-year-old Caucasian man was admitted to the Emergency Department for shortness of breath and cough. Computed tomog raphy (CT) imaging showed bilateral mild COVID-19-related pneumonia. He was hospitalized in the low-intensity COVID-19 unit, where he received O2 therapy and oral corticosteroids. Three weeks after discharge, a high-resolution CT (HRCT) found a giant bulla in the inferior lobe. The bulla was resected by video-assisted thoracoscopic surgery, and the patient recovered completely. In our patient, it is reasonable to suspect that the development of the bulla is a result of SARS-CoV-2 infection since no bulla was observed in the first HRCT two months before. SARS-CoV-2related pneumonia may be responsible for lung remodeling due to diffuse alveolar damage and later interstitial myofibroblastic proliferation. Corticosteroids might have played a role in increasing SARS-CoV-2 dystrophic action. COVID-19 leads to pulmonary damages, which are still partially unknown and might result in the development of bullae. In fit patients, surgical treatment can be carried out safely.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.